WK-MENU.ANS, 1996-01-26 from The Equalizer BBS (other)
October 22, 2026 at 10:45 AM
WK-MENU.ANS, 1996-01-26 from The Equalizer BBS (other)
Article a #Docusalut: Ivermectin inhibits acute chloroquine-induced scratching behavior by targeting p-NF-kB p65 and iNOS in mice https://hdl.handle.net/20.500.13003/27949 @grupnucoxuib.bsky.social @idisba.bsky.social #PublicaSalutIB
October 15, 2026 at 6:30 AM
Article a #Docusalut: Ivermectin inhibits acute chloroquine-induced scratching behavior by targeting p-NF-kB p65 and iNOS in mice https://hdl.handle.net/20.500.13003/27949 @grupnucoxuib.bsky.social @idisba.bsky.social #PublicaSalutIB
The end of a fantastic meeting on NF-kB @prbb.org.
-> nfkbcongress.com
Congratulations to Hanna Norbäck from the group of Judith Zaugg @unibas.ch for winning the EMBO Reports poster prize for her work "Cell-type-specific immune dysregulation in NFKB1-associated CVID" and the other prize winners.
-> nfkbcongress.com
Congratulations to Hanna Norbäck from the group of Judith Zaugg @unibas.ch for winning the EMBO Reports poster prize for her work "Cell-type-specific immune dysregulation in NFKB1-associated CVID" and the other prize winners.
October 10, 2026 at 9:24 AM
The end of a fantastic meeting on NF-kB @prbb.org.
-> nfkbcongress.com
Congratulations to Hanna Norbäck from the group of Judith Zaugg @unibas.ch for winning the EMBO Reports poster prize for her work "Cell-type-specific immune dysregulation in NFKB1-associated CVID" and the other prize winners.
-> nfkbcongress.com
Congratulations to Hanna Norbäck from the group of Judith Zaugg @unibas.ch for winning the EMBO Reports poster prize for her work "Cell-type-specific immune dysregulation in NFKB1-associated CVID" and the other prize winners.
Are you at the 7th International NF-kB Congress held at PRBB (Barcelona Biomedical Research Park) @prbb.org?
nfkbcongress.com
If yes (or work at PRBB), talk to our editor Achim Breiling there about your research, your manuscript looking for a home or any other publishing-related topic!
nfkbcongress.com
If yes (or work at PRBB), talk to our editor Achim Breiling there about your research, your manuscript looking for a home or any other publishing-related topic!
October 7, 2026 at 8:07 AM
Are you at the 7th International NF-kB Congress held at PRBB (Barcelona Biomedical Research Park) @prbb.org?
nfkbcongress.com
If yes (or work at PRBB), talk to our editor Achim Breiling there about your research, your manuscript looking for a home or any other publishing-related topic!
nfkbcongress.com
If yes (or work at PRBB), talk to our editor Achim Breiling there about your research, your manuscript looking for a home or any other publishing-related topic!
#FMR
Sea grapes (Caulerpa lentillifera) combat microbes, inflammation, cancer, and diabetes through Nrf2, NF-kB, and PI3K/Akt pathways, supporting nutraceutical and functional food development.
Details: https://www.maxapress.com/article/doi/10.48130/fmr-0026-0016
#SeaGrapes #FunctionalFood
Sea grapes (Caulerpa lentillifera) combat microbes, inflammation, cancer, and diabetes through Nrf2, NF-kB, and PI3K/Akt pathways, supporting nutraceutical and functional food development.
Details: https://www.maxapress.com/article/doi/10.48130/fmr-0026-0016
#SeaGrapes #FunctionalFood
October 5, 2026 at 1:25 AM
#FMR
Sea grapes (Caulerpa lentillifera) combat microbes, inflammation, cancer, and diabetes through Nrf2, NF-kB, and PI3K/Akt pathways, supporting nutraceutical and functional food development.
Details: https://www.maxapress.com/article/doi/10.48130/fmr-0026-0016
#SeaGrapes #FunctionalFood
Sea grapes (Caulerpa lentillifera) combat microbes, inflammation, cancer, and diabetes through Nrf2, NF-kB, and PI3K/Akt pathways, supporting nutraceutical and functional food development.
Details: https://www.maxapress.com/article/doi/10.48130/fmr-0026-0016
#SeaGrapes #FunctionalFood
Has anyone actually tried to get a fag paper between NF and KB?
October 4, 2026 at 8:38 AM
Has anyone actually tried to get a fag paper between NF and KB?
Mechanistic characterization revealed the receptor-free state of MyD88 as the key determinant of long term NF-kB activation and secondary response gene expression.
Do other examples of receptor-free signaling transduction exist?
Do other examples of receptor-free signaling transduction exist?
September 23, 2026 at 4:43 PM
Mechanistic characterization revealed the receptor-free state of MyD88 as the key determinant of long term NF-kB activation and secondary response gene expression.
Do other examples of receptor-free signaling transduction exist?
Do other examples of receptor-free signaling transduction exist?
The famous oscillations of NF-kB that govern TLR-induced gene expression are well-documented. What controls these oscillations and are they important for inflammatory cytokine production?
September 21, 2026 at 8:10 PM
The famous oscillations of NF-kB that govern TLR-induced gene expression are well-documented. What controls these oscillations and are they important for inflammatory cytokine production?
If you ditch Burnham, the public won’t accept another change, therefore you’ll get KB or NF.
September 17, 2026 at 7:11 PM
If you ditch Burnham, the public won’t accept another change, therefore you’ll get KB or NF.
Researchers examined immune cells called dendritic cells taken from patients with the disorder. They found that metformin lowers the activity of several key processes involved in inflammation, including STAT1 phosphorylation, the protein IRF7, interferon-related gene activity, NF-kB signaling,
September 15, 2026 at 11:59 PM
Researchers examined immune cells called dendritic cells taken from patients with the disorder. They found that metformin lowers the activity of several key processes involved in inflammation, including STAT1 phosphorylation, the protein IRF7, interferon-related gene activity, NF-kB signaling,
Bezisterim is an anti-inflammatory drug which crosses the blood-brain barrier. It works by inhibiting two major inflammatory pathways, ERK and Nf-kB.
The SARS-CoV-2 spike protein is known to trigger inflammation via these pathways...
2/
The SARS-CoV-2 spike protein is known to trigger inflammation via these pathways...
2/
September 15, 2026 at 2:29 PM
Bezisterim is an anti-inflammatory drug which crosses the blood-brain barrier. It works by inhibiting two major inflammatory pathways, ERK and Nf-kB.
The SARS-CoV-2 spike protein is known to trigger inflammation via these pathways...
2/
The SARS-CoV-2 spike protein is known to trigger inflammation via these pathways...
2/
These results may be relevant to attempts to disrupt IKK:NEMO interactions as an alternative IKK therapeutic. NEMO binds to >100 proteins, some not linked to NF-kB signalling, so these results may have wider implications for NEMO functions, e.g., aggrephagy (doi: 10.1038/s41467-023-44033-0).
September 15, 2026 at 7:42 AM
These results may be relevant to attempts to disrupt IKK:NEMO interactions as an alternative IKK therapeutic. NEMO binds to >100 proteins, some not linked to NF-kB signalling, so these results may have wider implications for NEMO functions, e.g., aggrephagy (doi: 10.1038/s41467-023-44033-0).
NEMO is a non-catalytic regulatory scaffold for the IKKs. It is absolutely required for activation of the canonical NF-kB pathway by TNF, IL-1 and LPS.
Former PhD student Jack Prescott knocked out the IKKs (doi: 10.1042/BCJ20210783) and noticed unexpected changes in NEMO abundance.
Former PhD student Jack Prescott knocked out the IKKs (doi: 10.1042/BCJ20210783) and noticed unexpected changes in NEMO abundance.
September 15, 2026 at 7:36 AM
NEMO is a non-catalytic regulatory scaffold for the IKKs. It is absolutely required for activation of the canonical NF-kB pathway by TNF, IL-1 and LPS.
Former PhD student Jack Prescott knocked out the IKKs (doi: 10.1042/BCJ20210783) and noticed unexpected changes in NEMO abundance.
Former PhD student Jack Prescott knocked out the IKKs (doi: 10.1042/BCJ20210783) and noticed unexpected changes in NEMO abundance.